Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2003-03-14
2009-08-18
Noakes, Suzanne M. (Department: 1656)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Reexamination Certificate
active
07575857
ABSTRACT:
The present invention relates to a screening method for the identification of protective substances which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells, as well as to recombinant constructs, host cells and transgenic animals for the implementation of this method. In addition, the present invention relates to a diagnostic method for the differential diagnosis of neurodegenerative and/or ischaemic diseases in mammals and the use of haemoglobin, a globin or a mutein or fusion protein thereof or a corresponding nucleic acid for the treatment of neurodegenerative and/or ischaemic diseases in mammals. The invention furthermore relates to constructs for gene therapy of such diseases.
REFERENCES:
patent: 6153427 (2000-11-01), King et al.
Burmester et al., a vertebrate globin expressed in the brain, Nature, Sep. 28, 2000, vol. 407, No. 6803, pp. 520-523.
Kanamori et al., induction of erythroid gene-expression by microcell fusion, experimental cell research, 1997 vol. 232, pp. 90-96.
Frietsch et al, Hemoglobin Is Expressed by Neurons in the Brain of Transgenic Mice Overexpressing Erythropoietin (EPO), Anesthesiology 2002 vol. 96: A761, p. 1.
Blau et al. Blood, 1993, 81(2):529-37.
Kaiho et al. Analytical Biochemistry, vol. 149, Issue 1, Aug. 15, 1985, pp. 117-120—Abstract only.
Pace et al., “Transgenic mouse model of pharmacologic induction of fetal hemoglobin: studies using a new ribonucleotide reductase inhibitor, Didox,”Am. J. Hematol., 452(2):136-141 (1994) abstract only.
Wagner et al., “Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin,”Blood, 97(2):536-542 (2001).
Broyles et al., “Specific repression of beta-globin promoter activity by nuclear ferritin”, PNAS, 98(16):9145-9150 (2001).
Brines et al., “Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury” PNAS, 97(19):10526-10531 (2000).
Dover et al., “Hydroxyurea Induction of Hemoglobin F Production in Sickle Cell Disease: relationship Between Cytotoxicity and F Cell Production”, Blood, 67(3):735-738 (1986).
International Search Report.
Maurer et al., “Analysis of brain mRNA of EPO overexpressing mice”, Pfluegers Archiv. European Journal of Physiology, 441:6S:R174 (2001).
D'Arcangelo, Gabriella et al., “Activation of Codependent Transcription Factors Is Required for Transcriptional Induction of thevgfGene by Nerve Growth Factor and Ras”, Molecular and Cellular Biology, Sep. 1996, pp. 4621-4631, vol. 16, No. 9, American Society for Microbiology, Washington, D.C.
Ruschitzka, Frank T. et al., “Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin”, Proceedings of the National Academy of Sciences of USA, Oct. 10, 2000, pp. 11609-11613, vol. 97, No. 21, National Academy of Sciences, Washington, D.C.
Bach Alfred
Kuschinsky Wolfgang
Maurer Martin
Schneider Armin
Noakes Suzanne M.
SYGNIS Bioscience GmbH & Co. KG
Townsend and Townsend / and Crew LLP
LandOfFree
Screening method for identifying protective substances for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening method for identifying protective substances for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method for identifying protective substances for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4092806